264
Fava M (2000). Weight gain and antidepressants. J Clin Psychiatry. 61(Suppl 11),
37–41.
Gluckman PD, Hanson MA, Beedle AS, Raubenheimer D. (2008) Fetal and neonatal
pathways to obesity. Front Horm Res 36, 61–72.
Grün F y Blumberg B (2009) Endocrine disrupters as obesogens. Mol Cell
Endocrinol. 304, 19–29.
Grun F. (2010) Obesogens. Curr Opin Endocrinol Diabetes Obes. 2010;17:453–459.
Gluckman PD, Hanson MA, Beedle AS, Raubenheimer D. (2008) Fetal and neonatal
pathways to obesity. Front Horm Res 36, 61–72.
Hoffmann IS, Alfieri AB, Cubeddu LX (2007) Effects of lifestyle changes and
metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive
Hispanics. J Hum Hypertens. 21, 571-578.
Inadera H, Shimomura A. Environmental chemical tributyltin augments adipocyte
differentiation. Toxicol Lett. 2005;159:226–34. doi: 10.1016/j.toxlet.2005.05.015.
Janesick A y Blumberg B (2012) Obesogens, Stem Cells and the Developmental
Programming of Obesit. Int J Androl 35, 437-448.
Jenssen, S (1972). The PCB Story. Ambi, 1, 123-131.
Kesselmeier J, Staudt M (1999). Biogenic volatile organic compounds (VOC): an
overview on emission, physiology and ecology. Journal of Atmospheric Chemistry. 33,
23-88.
Latini G Gallo F y Lughetti L (2010) Toxic environment and obesity pandemia: Is
there a relationship? Ital J Pediatr 36, 1-3.
Panagiotakos DB, Chrysohoou C, Pitsavos C, Stefanadis C (2006). Association
between the prevalence of obesity and adherence to the Mediterranean diet: the ATTICA
study. Nutrition. 22, 449-456.
Rocchini AP (2002) Obesity hypertension. Am J Hypertens. 15(2Pt2), 50-52.
vom Saal FS, Nagel SC, Coe BL, Angle BM, y Taylor JA (2012). The estrogenic
endocrine disrupting chemical bisphenol A, (BPA) and obesity. Molecular and Cellular
Endocrinology 354, 74–84.
World Health Organization. Obesity (1997): Preventing and Managing the Global
Epidemic. Geneva: WHO; 1997.
